Immediately after fifteen times of hyperbaric chamber therapy, the OCT reveals a reduction in retinal thickness and OCTA demonstrates improvement in retinal circulation. OPDIVO® (nivolumab) is a prescription medicine employed in combination with YERVOY® (ipilimumab) to deal with adults wi